MetaVia, Inc. (MTVA)
1.11
-0.08
(-6.72%)
USD |
NASDAQ |
May 15, 16:00
1.11
0.00 (0.00%)
After-Hours: 07:07
MetaVia EPS Diluted (Quarterly) : -0.7867 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -2.932 |
| Phio Pharmaceuticals Corp. | -0.3446 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.823M |
| Total Expenses (Quarterly) | 3.823M |
| Enterprise Value | 14.66M |
| Earnings Yield | -542.2% |
| Normalized Earnings Yield | -550.36 |